DXCM: 10-K Risk Factor Changes

2025 vs 2024  ·  SEC EDGAR  ·  2026-07-05
Other years: 2026 vs 2025
✓ Deterministic extraction — no AI-generated data

Classification is based on semantic text similarity scoring and may include approximations. “No match” means no high-confidence textual match was found — not necessarily that a section was removed.

0
New Risks
3
Removed
8
Modified
66
Unchanged
🟡 Modified We conduct business in a heavily regulated industry and if we fail to comply with applicable laws and government regulations, we could become subject to penalties, be excluded from participation in government programs, and/or be required to make significant changes to our operations. 🔒
🟡 Modified Sustainability (including environmental, social and governance) regulations, policies and provisions could expose us to numerous risks. 🔒
🔴 No Match in Current Filing We are subject to cost-containment efforts by third-party payors that could result in reduced product pricing and/or sales of our products and cause a reduction in revenue. 🔒
🔴 No Match in Current Filing Our CGM systems currently have regulatory marketing authorization limited to individual patient home-use, and have otherwise not received clearance or approval from the FDA or other regulators for use in hospital or other in-patient facility settings, although the FDA has advised us that it will not object to the use of our CGM systems in such settings during the COVID-19 pandemic. Our potential supply of our CGM systems for use in this environment during the COVID-19 pandemic may present risks to our business. 🔒
🔴 No Match in Current Filing The warrants related to the 2023 Notes and our common stock. 🔒
🟡 Modified If we experience decreasing prices for our products and we are unable to reduce our expenses, including the per unit cost of producing our products, there may be a material adverse effect on our business, results of operations, financial condition and cash flows. 🔒
🟡 Modified Our business could be negatively impacted by evolving expectations and challenges relating to implementing sustainability (including environmental, social and governance) initiatives, setting sustainability-related goals, collecting sustainability-related data, and disclosing sustainability-related information. 🔒
🟡 Modified If our manufacturing capabilities are insufficient to produce an adequate supply of product at appropriate quality levels, our growth could be limited and our business could be harmed. 🔒
🟡 Modified Failure to obtain any required regulatory authorization in international jurisdictions will prevent us from marketing our products abroad. 🔒
🟡 Modified Our products may not achieve or maintain market acceptance. 🔒
🟡 Modified Our Amended Credit Agreement imposes restrictions on us that may adversely affect our ability to operate our business. 🔒
11 changes in this historical filing

Historical year-over-year comparisons (2025 vs 2024 and earlier) are available on the Pro plan.

Get full access — from $29/month Already a Pro subscriber? View full diff →